Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005954 · ClinicalTrials.gov registry record · Phase 2
Temozolomide in Treating Patients With Brain Metastases
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00005954 is a Phase 2 study that has completed, run by Duke University.
The verdict
NCT00005954, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating patients who have brain metastases.
Interventions
- DRUG temozolomide
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-08 |
| Est. Completion | 2003-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00005954
The ClinicalTrials.gov registry entry for NCT00005954 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which temozolomide is the first listed.
NCT00005954 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00005954 about?
NCT00005954 is a clinical study titled "Temozolomide in Treating Patients With Brain Metastases". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating patients who have brain metastases.
What is the current status of trial NCT00005954?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-08. Estimated completion is 2003-06.
What interventions are being tested in trial NCT00005954?
The interventions under investigation include: temozolomide (DRUG).
Who is sponsoring clinical trial NCT00005954?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.